At the news
? NEUTRALIMPACT 3/10 3 filed Jul 2, 2026 at 17:59 ET
Dr. Nerissa Kreher has been appointed as a director of Xeris Biopharma Holdings, Inc., effective July 1, 2026, and filed a Form 3 initial statement of beneficial ownership. This is a routine administrative filing with no disclosure of actual holdings or material financial impact.
- Dr. Nerissa Kreher appointed as director, effective 2026-07-01
- Form 3 filed to report initial beneficial ownership (no ownership amounts disclosed)
- Power of Attorney granted to John Shannon, Beth Hecht, and Steve Pieper for Section 16 filings
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access